Regulatory Writing: New developments in public disclosure of clinical trials - Volume 24, Issue

In April this year, the World Health Organisation (WHO) issued a statement on the public disclosure of clinical trial results (the full statement is available from http://www.who.int/ictrp/results/reporting/en/). In essence, this statement…

In this issue… The Medical Writing Business - Volume 24, Issue

As medical writers, we strive not just to survive but to thrive. Threats, opportunities, and complications come from many directions, and how to best position ourselves, our departments, and our companies requires much thought. Money is important…

Veterinary Medical Writing - Volume 29, Issue

All three articles in this Veterinary Medical Writing section were written when COVID-19 was not classified as a pandemic. Yet all three articles tie into the current narrative of regulation in veterinary medicine and the need for communication…

Where have all the UK entry level pharmaceutical regulatory medical writing jobs gone? - Volume 25, Issue

Veterinary Medical Writing - Volume 30, Issue

This edition of Veterinary Medical Writing signals a changing of the guard as Karim Montasser passes on the reins, having guided this section of Medical Writing with a steady hand during his tenure. And it is mindful of those auspicious shoes to…

Medical Writing Teaching - Volume 25, Issue

Teaching manuscript writing in Africa I’m glad to have the opportunity to contribute to this new regular feature in MEW – ’Teaching medical writing’. Why write about teaching in Africa? Well, Claire Gudex – who will manage the section – thought my…

Medical Communications and Writing for Patients - Volume 31, Issue

In this issue, the Medical Communications and Writing for Patients section features two articles. The first piece, by Simon Linacre,  is a summary of the excellent work just completed by the Med Comms SIG. They have devised, run, and collated the res…

The Regulatory Public Disclosure Special Interest Group - Volume 27, Issue

Who are we and what do we do ? The Regulatory Public Disclosure Special Interest Group (RPD SIG) was first conceived in December 2015 and is a group of EMWA members supporting other EMWA members. The RPD SIG objective is: “to provide a forumfor the…

Pesticide dossiers, an opportunity for medical writers - Volume 23, Issue

Pesticides, also known as crop protection products, are approved for sale through a process similar to that for authorising human medicines. For example, the toxicology data submitted are nearly identical to the nonclinical data generated for a…

Document management systems for medical writing - Volume 28, Issue

Clinical trial data are rightfully protected by robust regulations; given these requirements and increasing demands from clients, a validated and compliant electronic document management system is now a necessity for established medical writing…